Roche's Cobas 6800/8800 Testing Systems Launched - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 03, 5:55PM CDT
Roche (RHHBY) announced that its cobas 6800/8800 systems -- two integrated and fully automated molecular testing systems for blood and plasma donor screening are commercially available in markets which accept the CE mark.
INTERMUNE SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Class Action Against InterMune, Inc. in Connection With Sale of Company to Roche Holding AG -- ITMN
GlobeNewswire - Wed Sep 03, 4:40PM CDT
The Law Offices of Vincent Wong notifies investors of claims of breaches of fiduciary duty against the Board of Directors of InterMune, Inc. (Nasdaq:ITMN) ("InterMune"